{"transactions":[{"id":2316730,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":128728,"kind":"person","name":"Hu Cynthia W.","position":1,"cik":"0001364709","reported_name":"Hu Cynthia W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer&Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-29T00:30:10.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":1560000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The option grant has an exercise price of $1.48 Canadian Dollars. This represents the exercise price in United States Dollars."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option shall vest and become exercisable on December 6, 2022; the remaining shares underlying the option shall vest and become exercisable with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":1560000,"derivative":{"exercise_price":1.18,"expiration_date":"2027-03-23","underlying":"Subordinate Voting Shares","underlying_shares":1560000},"source":{"system":"sec-edgar","filing":"0001209191-22-021393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122021393/doc4.xml","form_type":"4"}},{"id":2316729,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":128728,"kind":"person","name":"Hu Cynthia W.","position":1,"cik":"0001364709","reported_name":"Hu Cynthia W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer&Secretary"}}],"security":"Subordinate Voting Shares","published_at":"2022-03-29T00:30:10.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, 25% shall vest on December 6, 2022, with 1/48th vesting at the end of each month thereafter for the succeeding 36 months, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":1200000,"source":{"system":"sec-edgar","filing":"0001209191-22-021393","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122021393/doc4.xml","form_type":"4"}},{"id":2597471,"issuer":{"id":109458,"kind":"organization","name":"Decibel Therapeutics, Inc.","symbol":"DBTX"},"owners":[{"id":128728,"kind":"person","name":"Hu Cynthia W.","position":1,"cik":"0001364709","reported_name":"Hu Cynthia W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-18T16:55:03.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on August 16, 2021. The shares underlying the option are scheduled to vest with respect to 25% of the shares on the first anniversary of the grant date and as to the balance of such shares in 36 equal month installments thereafter until the fourth anniversary of the grant date, subject to the reporting person's continued service."}],"balance_after":150000,"derivative":{"exercise_price":7.37,"expiration_date":"2031-08-15","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-21-033466","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364709/000089924321033466/doc4.xml","form_type":"4"}},{"id":3681757,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":128728,"kind":"person","name":"Hu Cynthia W.","position":1,"cik":"0001364709","reported_name":"Hu Cynthia W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Gen Counsel & Secretary"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-01-31T19:19:27.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On March 2, 2016, the reporting person was granted an option to purchase shares of common stock that would vest upon achievement of certain performance based conditions. On January 29, 2019, the Compensation Committee certified that the performance based condition relating to the vesting of 75,000 options had been satisfied on October 18, 2018, resulting in vesting of the options."}],"balance_after":75000,"derivative":{"exercise_price":0.88,"exercise_date":"2019-01-29","expiration_date":"2026-03-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001144204-19-004170","document":"tv512145_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420419004170/tv512145_4.xml","form_type":"4"}},{"id":3695852,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":128728,"kind":"person","name":"Hu Cynthia W.","position":1,"cik":"0001364709","reported_name":"Hu Cynthia W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Gen Counsel & Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-15T16:02:14.000Z","date":"2019-01-14","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vested as follows: 25% on the date of grant, and an additional 25% on each successive anniversary of the grant date until the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.76,"expiration_date":"2019-01-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001144204-19-001739","document":"tv511069_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420419001739/tv511069_4.xml","form_type":"4"}},{"id":3695851,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":128728,"kind":"person","name":"Hu Cynthia W.","position":1,"cik":"0001364709","reported_name":"Hu Cynthia W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2019-01-15T16:02:14.000Z","date":"2019-01-14","kind":"tax_withholding","acquired":false,"shares":3100,"price":3.79,"value":11749.0,"ownership":{"direct":true},"balance_after":29685,"source":{"system":"sec-edgar","filing":"0001144204-19-001739","document":"tv511069_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420419001739/tv511069_4.xml","form_type":"4"}},{"id":3695850,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":128728,"kind":"person","name":"Hu Cynthia W.","position":1,"cik":"0001364709","reported_name":"Hu Cynthia W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2019-01-15T16:02:14.000Z","date":"2019-01-14","kind":"exercise","acquired":true,"shares":15000,"price":1.76,"value":26400.0,"ownership":{"direct":true},"balance_after":32785,"source":{"system":"sec-edgar","filing":"0001144204-19-001739","document":"tv511069_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420419001739/tv511069_4.xml","form_type":"4"}},{"id":4190445,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":128728,"kind":"person","name":"Hu Cynthia W.","position":1,"cik":"0001364709","reported_name":"Hu Cynthia W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Gen Counsel and Secretary"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-10-06T17:01:01.000Z","date":"2017-07-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2017, the reporting person was granted an option to purchase 50,000 shares of common stock, which vested upon the achievement of a performance condition on July 10, 2017."}],"balance_after":50000,"derivative":{"exercise_price":1.0064,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-17-051696","document":"v476599_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420417051696/v476599_4.xml","form_type":"4"}},{"id":4196130,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":128728,"kind":"person","name":"Hu Cynthia W.","position":1,"cik":"0001364709","reported_name":"Hu Cynthia W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Gen Counsel and Secretary"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-10-03T18:49:40.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 15, 2012, the reporting person was granted an option to purchase 50,000 shares of common stock, which vested upon the achievement of a performance condition on September 29, 2017."}],"balance_after":50000,"derivative":{"exercise_price":1.985,"expiration_date":"2022-08-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-17-051253","document":"v476424_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420417051253/v476424_4.xml","form_type":"4"}},{"id":4287622,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":128728,"kind":"person","name":"Hu Cynthia W.","position":1,"cik":"0001364709","reported_name":"Hu Cynthia W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Gen Counsel and Secretary"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-09T17:03:29.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis."}],"balance_after":100000,"derivative":{"exercise_price":1.0064,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001144204-17-031975","document":"v468780_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420417031975/v468780_4.xml","form_type":"4"}}]}